Stephen Pianko

Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options

Ira M. Jacobson, Stuart C. Gordon, Kris V. Kowdley et al. · New England Journal of Medicine · 2013 · 1.1K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection

Graham R. Foster, Nezam H. Afdhal, Stuart K. Roberts et al. · New England Journal of Medicine · 2015 · 850 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Efficacy of Sofosbuvir Plus Ribavirin With or Without Peginterferon-Alfa in Patients With Hepatitis C Virus Genotype 3 Infection and Treatment-Experienced Patients With Cirrhosis and Hepatitis C Virus Genotype 2 Infection

Graham R. Foster, Stephen Pianko, Ashley Brown et al. · Gastroenterology · 2015 · 250 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity

John G. McHutchison, John E. Ware, Martha Bayliss et al. · Journal of Hepatology · 2001 · 208 citations

Pharmacy, Internal Medicine, Pharmacotherapy +12

NS5A resistance-associated substitutions in patients with genotype 1 hepatitis C virus: Prevalence and effect on treatment outcome

Stefan Zeuzem, Masashi Mizokami, Stephen Pianko et al. · Journal of Hepatology · 2017 · 203 citations · Full text

Life Sciences, Genetics, Infectious Diseases +17